AZN

Astrazeneca plc

168.37

Sep 22 • 3:59 PM ET +0.27 (0.16%)

168.37

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - General United Kingdom Mega NYSE

Peers: LLY MRK PFE ABBV JNJ NVS GSK BMY SNY AMGN

| Held by: AVDE DIHP PVAL DFIC PBPH PPH FVD DFAX BDYN IDEQ

Scroll to Statements

Index	-
Market Cap	261.12B
Enterprise Value	288.47B
Income	10.45B
Sales	61.37B
Book/sh	32.43
Cash/sh	3.20
Dividend Est.	3.34 (1.98%)
Dividend TTM	3.23 (1.92%)
Dividend Ex-Date	Aug 07, 2026
Dividend Gr. 3/5Y	1.78% 3.25%
Payout	47.19%
Employees	96100
IPO	Oct 17, 2003

P/E	25.16
Forward P/E	14.64
PEG	1.24
P/S	4.26
P/B	5.19
P/C	52.56
P/FCF	24.02
EV/EBITDA	14.36
EV/Sales	4.70
Quick Ratio	0.67
Current Ratio	0.89
Debt/Eq	0.64
LT Debt/Eq	0.52
Option/Short	Yes / Yes

EPS (ttm)	6.69
EPS next Y	11.50
EPS next Q	2.61
EPS this Y	12.11%
EPS next Y	12.00%
EPS next 5Y	11.83%
EPS past 3/5Y	45.90% 22.05%
Sales past 3/5Y	9.82% 16.31%
EPS Y/Y TTM	25.90%
Sales Y/Y TTM	8.61%
EPS Q/Q	2.26%
Sales Q/Q	6.41%
Earnings	Jul 27 BMO
EPS/Sales Surpr.	5.98% -0.32%

Insider Own	3.43%
Insider Trans	-0.02%
Inst Own	61.03%
Inst Trans	-1.03%
ROA	9.15%
ROE	21.99%
ROIC	13.69%
Gross Margin	73.93%
Oper. Margin	22.38%
Profit Margin	17.02%
SMA20	2.95%
SMA50	2.55%
SMA200	-7.81%
Trades

Shs Outstand	1.55B
Shs Float	1.50B
Short Float	0.19%
Short Ratio	0.87
Short Interest	2.90M
52W High	212.71 -20.85%
52W Low	146.10 15.24%
Volatility	1.56% 1.76%
ATR (14)	3.44
RSI (14)	58.50
Beta	0.33
Rel Volume	0.69
Avg Volume	3.34M
Volume	2,305,845

Perf Week	4.03%
Perf Month	1.44%
Perf Quarter	-6.99%
Perf Half Y	-8.53%
Perf YTD	-4.06%
Perf Year	7.37%
Perf 3Y	22.07%
Perf 5Y	44.10%
Perf 10Y	153.19%
Recom	1.20
Target Price	219.33
Prev Close	168.10
Price	168.37
Change %	0.16%

Date	Action	Analyst	Rating Change
Sep-15-26	Upgrade	Deutsche Bank	Sell → Hold
Sep-09-26	Initiated	RBC Capital Mkts	Outperform
Jul-13-26	Downgrade	HSBC Securities	Buy → Hold

Sep-21-26 11:55AM	Novo Nordisk shares plunge over 7% as new targets fail to reassure investors (Proactive)
08:20AM	Novo Nordisk Stock Drops 5.6% as 2030 Goals Match Peers (GuruFocus.com)
Sep-17-26 03:16PM	AstraZeneca Gains as Enhertu Clears England's Value Gate (GuruFocus.com)
01:00AM	The West is hooked on Chinese drugs but they could save your life (The Telegraph)
Sep-16-26 03:03PM	AstraZeneca Shares Rise as J.P. Morgan Stays Overweight (GuruFocus.com)
10:37AM	Loading…
10:37AM	AstraZeneca shares oversold after trial flops and merger talk, says UBS (Proactive)
07:05AM	AstraZeneca's news flow next year could sustain drugs group beyond 2030, says leading bank (Proactive)
Sep-15-26 08:02AM	WCLC 26: A new ADC era, China questions and AstraZenecas spotlight (BioPharma Dive)
07:11AM	CLLS Stock Heads For 14-Month Low After 40% Rout: Citizens Flags Delayed Cellectis Catalysts After Cancer Pipeline Pivot (Stocktwits)
Sep-14-26 12:46PM	AstraZenecas cancer pipeline posts two wins and a loss (Clinical Trials Arena)
08:30AM	AstraZenecas newly approved pill fails frontline breast cancer study (BioPharma Dive)
08:10AM	Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results (InvestorsHub)
08:01AM	AstraZeneca breast cancer drug fails trial but Citi keeps 'buy' rating (Proactive)
Sep-11-26 06:11PM	AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss Executive Disappointed, Reiterates Breast Cancer Focus (Stocktwits)
Sep-10-26 08:30AM	AstraZeneca's $5bn drug promise is no 'buy' signal for Deutsche (Proactive)
02:02PM	Loading…
Sep-09-26 02:02PM	AstraZeneca Falls 1.3% Despite a 34% COPD Breakthrough (GuruFocus.com)
02:01PM	Amgen's Imdelltra Sales Surge 115% as Lung-Cancer Combination Meets Major Goals (GuruFocus.com)
11:56AM	ERS 2026: tozorakimabs groundbreaking exacerbation reduction sets a new bar in COPD (Clinical Trials Arena)
11:46AM	VERAXA Biotech Designates Raju Willener as CFO (Exec Edge)
09:00AM	AstraZeneca COPD data back Citi's $7b peak sales case (Proactive)
06:10AM	Amgen, AstraZeneca combination improves survival measures in late-stage lung cancer study (InvestorsHub)
05:48AM	Merck pairs ADCs with Keytruda in womens cancer push (Pharma Voice)
Sep-08-26 12:35PM	AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival Test (GuruFocus.com)
10:41AM	Roivant surges on exceptional results; Bristol Myers touts first-of-its-kind CAR-T therapy (BioPharma Dive)
08:28AM	AstraZeneca tozorakimab COPD Phase 3 trial results 2026 (Quartz)
Sep-07-26 10:03AM	Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval (Proactive)
07:14AM	Evinova and Lothar Medical partner on respiratory device trials (Medical Device Network)
05:35AM	FDA approves AstraZeneca's Etcamah combo for advanced breast cancer (Pharmaceutical Business Review)
Sep-04-26 07:56AM	This week in charts: China deals, stock flatlines and Lillys M&A spree (BioPharma Dive)
Sep-03-26 08:00AM	Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT) (FinanceWire)
04:36PM	Loading…
Sep-02-26 04:36PM	Top Stock Reports for AMD, Costco & AstraZeneca (Zacks)
Sep-01-26 01:19PM	AstraZeneca's $80 Billion Plan Gets Another Tagrisso Win (GuruFocus.com)
Aug-30-26 10:29PM	SLS Stock Rises Overnight: Healthcare Execs Tout AML Drug As Game Changer Ahead Of Final Trial Trigger (Stocktwits)
Aug-28-26 05:18PM	IONS, AZN Stocks Fall On Full Data From Failed Cardiomyopathy Trial Jefferies Sees Neutral To Negative Readthrough To ALNY (Stocktwits)
08:54AM	Alnylam stock drops on rival heart trial: Why analysts see core business safe (Investing.com)
06:58AM	AstraZeneca, Ionis data spark debate about RNA drugs impact on deadly heart disease (BioPharma Dive)
Aug-27-26 03:10PM	AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success (GuruFocus.com)
07:58AM	New data could widen use of AstraZeneca, Amgen immune disease drug (BioPharma Dive)
07:30AM	Amgen-AstraZenecas Tezspire nets another Phase III inflammatory disease win (Clinical Trials Arena)
03:18AM	AstraZeneca drug succeeds in trial for swallowing disorder (Proactive)
Aug-26-26 01:51PM	Summits Global Lung Cancer Trials Gain Credibility After Akesos Phase 3 Data, Says Guggenheim (Stocktwits)
07:29AM	Akeso logs Phase III success in second tumour type for ivonescimab (Clinical Trials Arena)
Aug-25-26 02:32AM	AstraZeneca prices 2.55bn euro bond sale across four tranches (Proactive)
Aug-20-26 12:29PM	Big Pharma is Making Chinese Biotechs Prosper (Moby)
Aug-19-26 06:30AM	HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation (TMX Newsfile)
05:30AM	The Key to Pharma M&A: Never Shopping Hungry (The Wall Street Journal)
Aug-18-26 09:00AM	AstraZeneca maintains Citi 'buy' rating despite mixed pipeline updates (Proactive)
07:13AM	AstraZeneca scores in lung cancer; Sandoz inks a China deal (BioPharma Dive)
Aug-17-26 04:42PM	AstraZeneca Halts Key Lung-Cancer Trial--But Shares Barely Flinch (GuruFocus.com)
10:37AM	HUTCHMED shares rise as lung cancer drug trial hits key targets (Proactive)
10:07AM	AstraZenecas Lung Cancer Bet Hits a Dead End (Moby)
02:41AM	AstraZeneca lung cancer drug combination extends survival in trial (Proactive)
02:41AM	AstraZeneca halts lung cancer trial in fresh pipeline setback (Proactive)
Aug-13-26 04:00PM	Sarah Ketterer's Top Q2 2026 Move: AstraZeneca PLC at a 3.92% Portfolio Impact (GuruFocus.com)
Aug-12-26 12:00AM	How AstraZenecas $400bn deal unravelled (Financial Times)
Aug-07-26 03:30PM	Roche Stock Jumps as Morgan Stanley Sees Drug Breakout (GuruFocus.com)
06:02AM	Significant demand for Revolution drug; Intellia pinpoints liver toxicity culprit (BioPharma Dive)
01:00AM	Why FTSE companies are heading for the exit (The Telegraph)
01:00AM	The 20-year exodus hollowing out the London stock market (The Telegraph)
01:00AM	How the FTSE became a departure lounge for British companies (The Telegraph)
12:01AM	For Modernas Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off (The Daily Upside)
Aug-06-26 05:26AM	What the AstraZeneca-BMS rumors reveal about pharma megamergers (Pharma Voice)
Aug-05-26 12:17PM	AstraZeneca-Bristol Myers $400B Merger Buzz Cools After Report Denies Talks There Never Was A Deal To Be Done (Stocktwits)
10:01AM	AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation (InvestorsHub)
09:40AM	Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls (The Fly)
09:11AM	AstraZeneca and Bristol Myers Squibb merger talks denied (Quartz)
09:11AM	Senior source denied AstraZeneca and Bristol Myers Squibb were ever in merger talks (Quartz)
09:00AM	AZN spikes 6% after report it denies AstraZeneca-BMS merger talks (Investing.com)
08:10AM	AstraZeneca stock jumps and Bristol Myers shares fall on report of 'no discussions' (MarketWatch)
05:45AM	SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics (Medical Device Network)
Aug-04-26 02:45PM	AstraZeneca Faces Fresh Pressure As $400B Bristol Myers Deal Talks Reportedly Persist (Stocktwits)
11:23AM	SOPH Stock Heads For Best Day In Over 8 Months Whats Driving Todays Super Rally? (Stocktwits)
10:32AM	Brokers split on AstraZeneca merger talk as shares recover some ground (Proactive)
06:15AM	SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies (PR Newswire)
05:30AM	How a pharma megamerger could squelch R&D (Axios)
Aug-03-26 09:46PM	Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today? (Stocktwits) -6.88%
04:29PM	AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks (GuruFocus.com)
04:26PM	Wall Street rallies, Dow closes at record on Iran talks optimism (Reuters)
01:27PM	AstraZeneca Eyes a Pharma Megamerger Nobody Asked For (Moby)
12:40PM	AstraZeneca Investors See Little Logic in Bristol Tie-Up (Bloomberg)
12:03PM	AstraZeneca shares slump after $400bn BMS merger rumours (Pharmaceutical Technology)
11:52AM	Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen? (Investing.com)
11:40AM	Astra Buying Bristol Makes No Sense, Fazeli Says (Bloomberg)
11:20AM	AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed' (CNBC TV)
09:27AM	Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca (Investopedia)
08:30AM	AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb (Quartz)
08:26AM	AstraZeneca, Bristol Myers Squibb exploring merger talks (Quartz)
08:04AM	AstraZeneca Weighs a Deal Its CEO Said It Didn't Need (GuruFocus.com)
07:24AM	The gap between big tech and the rest of the market just vanished. Here's what it means for investors. (MarketWatch)
07:02AM	Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb (Proactive)
06:48AM	Palantir, Micron, SK Hynix, Alibaba, and More Stocks That Explain Today's Market (Barrons.com)
06:43AM	AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. (MarketWatch)
05:54AM	Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca (Barrons.com)
03:24AM	AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb (Proactive)
02:17AM	FTSE 100 Live: London lagging as AstraZeneca offsets gains from oil drop (Proactive)
02:17AM	FTSE 100 Live: Blue-chips start down as AstraZeneca and oil giants sink (Proactive)
Aug-02-26 10:48PM	Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? (Stocktwits)
05:14PM	AstraZeneca slides 7% after report of merger talks with Bristol Myers Squibb (Investing.com)
04:20PM	AstraZeneca plots £300bn tie-up with US rival (The Telegraph)
Jul-30-26 05:12AM	How Telix landed a $2.1 billion radiopharma deal with Regeneron (Pharma Voice)

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

M.B.A.Mr. Pascal Claude Roland Soriot D.V.M.

CFO & Executive DirectorDr. Aradhana Sarin M.D.

EVP of Global opt. & ITMs. Pam P. Cheng

Head of Investor RelationsMr. Joris Silon

CHROMr. Jeffrey Pott J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sharma Mani	See Remarks	Aug 08 '26	Buy	160.57	20	3,249	19,288	Sep 11 04:05 PM
Sharma Mani	See Remarks	May 20 '26	Sale	185.78	11,893	2,209,482	19,262	May 22 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc

Upgrade your Finviz experience